Cancer Under Siege
Published on: June 2, 2022
![An artist’s interpretation of an immune cell attacking a cancer cell. Illustration: Microverse](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-core-image_20230522131522.png?size=xlarge)
Cancer is too great a challenge to tackle alone. With new partnerships and new technologies spurring rapid innovation, we’re charging ahead to change lives and restore hope for people living with cancer.
I have never been more excited about the potential of emerging therapeutic agents in oncology. Through the marriage of ground-breaking science, AI, and novel technologies, we aspire to unlock cancer biology that has until now seemed out of reach and bring in a new wave of immunotherapies for areas of high unmet need.
![Valeria Fantin](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-image1_20230522131522.jpg?size=small)
Valeria Fantin
Head of Oncology Research
![](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-image2_20230522131522.png?size=large)
NANOBODY® technology
If we string together tiny antibody fragments, could we make medicines that have never been thought of before?
![](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-image3_20230522131522.png?size=large)
Antibody-Drug Conjugates
What if an antibody could deliver a small amount of medicine straight to tumor cells – could flooding the body with anti-cancer drugs become a thing of the past?
![](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-image4_20230522131522.png?size=large)
SYNTHORIN™ Technology
What if we expand the genetic alphabet – could we access biology in ways that we once thought impossible?
![](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-image5_20230522131522.png?size=large)
Natural Killer Cell Therapies
What if natural killer cells could be turned into medicines for people with cancer?
Our incredibly talented, creative scientists are motivated to have a meaningful impact on the lives of people with cancer. Leveraging a expansive toolbox that spans small molecules, peptides, proteins, cells, and genes, we’re determined to develop medicines that are smarter, safer, and more effective than ever before.
![Matt Truppo](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-image6_20230522131522.jpg?size=small)
Matt Truppo
Global Head of Research Platforms
![](/optim/dotcom/content-app/articles/social-impact/cancer-under-siege/article21-social-impact-image7_20230522131522.jpg?size=large)
Our oncology ambition
With new ideas spurring innovation, we’re charging ahead to help change lives and restore hope to people living with cancer
Explore more
![](/optim/dotcom/content-app/articles/our-science/mrna-technology-platform/article12-ourscience-core-image_20230522121212.jpg?size=medium)
mRNA Technology: Vaccines and Beyond
MAT-GLB-2202118 v 1.0 | June 2022